Page last updated: 2024-08-24

bmy 25067 and Carcinoma, Transitional Cell

bmy 25067 has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Au, JL; Yen, WC1

Other Studies

1 other study(ies) available for bmy 25067 and Carcinoma, Transitional Cell

ArticleYear
Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
    Pharmaceutical research, 1997, Volume: 14, Issue:2

    Topics: Administration, Intravesical; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Survival; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1997